Clinical Efficacy, Tolerability, and Safety of SAM486A, a...

Clinical Cancer Research 2004 / 02 Vol. 10; Iss. 4

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma: Results from a Phase II Multicenter Study

Pless, M., Belhadj, K., Menssen, H. D., Kern, W., Coiffier, B., Wolf, J., Herrmann, R., Thiel, E., Bootle, D., Sklenar, I., Muller, C., Choi, L., Porter, C., Capdeville, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-0977-03
Date:
February, 2004
File:
PDF, 125 KB
english, 2004
Conversion to is in progress
Conversion to is failed